Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-30
- Last Posted Date
- 2014-10-16
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 2053
- Registration Number
- NCT00308737
- Locations
- 🇺🇸
Franklin Square Hospital, Baltimore, Maryland, United States
🇺🇸Endocrine Research - Physician's East PA, Greenville, North Carolina, United States
🇺🇸Northwest Medical Center, Phoenix, Arizona, United States
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2014-10-16
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 589
- Registration Number
- NCT00308308
- Locations
- 🇺🇸
Coastal Biomedical Research Inc, Santa Monica, California, United States
🇺🇸Laureate Clinical Research Group, Atlanta, Georgia, United States
🇺🇸John H Stoger Jr Hospital of Cook County, Chicago, Illinois, United States
Vaccine Therapy in Treating Patients With Stage IV Melanoma
- First Posted Date
- 2004-02-16
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 26
- Registration Number
- NCT00023647
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Stage IV Melanoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-05-12
- Lead Sponsor
- Mannkind Corporation
- Target Recruit Count
- 19
- Registration Number
- NCT00033228
- Locations
- 🇺🇸
Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath